These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

277 related items for PubMed ID: 2347415

  • 1. Static and flow cytometric DNA analysis compared to histologic prognostic factors in a cohort of stage T2 breast cancer.
    Arnerlöv C, Emdin SO, Roos G, Angström T, Bjersing L, Angquist KA, Jonsson H.
    Eur J Surg Oncol; 1990 Jun; 16(3):200-8. PubMed ID: 2347415
    [Abstract] [Full Text] [Related]

  • 2. Prognostic value of DNA ploidy in breast cancer stage I-II.
    Cufer T, Lamovec J, Bracko M, Lindtner J, Us-Krasovec M.
    Neoplasma; 1997 Jun; 44(2):127-32. PubMed ID: 9201293
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Prognostic value of S-phase fraction in lymph-node-negative breast cancer by image and flow cytometric analysis.
    Peiró G, Lerma E, Climent MA, Seguí MA, Alonso MC, Prat J.
    Mod Pathol; 1997 Mar; 10(3):216-22. PubMed ID: 9071729
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Flow cytometry detected S-phase fraction and ploidy as prognostic parameters in primary, node-negative breast cancer].
    Winter K, Eidtmann H, Jonat W.
    Geburtshilfe Frauenheilkd; 1994 May; 54(5):291-4. PubMed ID: 8050690
    [Abstract] [Full Text] [Related]

  • 9. DNA ploidy and survival in breast cancer patients.
    Cornelisse CJ, van de Velde CJ, Caspers RJ, Moolenaar AJ, Hermans J.
    Cytometry; 1987 Mar; 8(2):225-34. PubMed ID: 3582068
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Influence of cellular DNA content on disease-free survival of Stage II breast cancer patients.
    Hedley DW, Rugg CA, Ng AB, Taylor IW.
    Cancer Res; 1984 Nov; 44(11):5395-8. PubMed ID: 6488193
    [Abstract] [Full Text] [Related]

  • 15. S-phase fraction determined on fine needle aspirates is an independent prognostic factor in breast cancer - a multivariate study of 770 patients.
    Gazic B, Pizem J, Bracko M, Cufer T, Borstnar S, Pohar-Marinsek Z, Us-Krasovec M.
    Cytopathology; 2008 Oct; 19(5):294-302. PubMed ID: 18070112
    [Abstract] [Full Text] [Related]

  • 16. DNA flow cytometric analysis of clinical stage I endometrial carcinomas with lymph node metastases.
    Coleman RL, Schink JC, Miller DS, Bauer KD, August CZ, Rademaker AW, Lurain JR.
    Gynecol Oncol; 1993 Jul; 50(1):20-4. PubMed ID: 8349159
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Genetic analysis of 53 lymph node-negative breast carcinomas by CGH and relation to clinical, pathological, morphometric, and DNA cytometric prognostic factors.
    Hermsen MA, Baak JP, Meijer GA, Weiss JM, Walboomers JW, Snijders PJ, van Diest PJ.
    J Pathol; 1998 Dec; 186(4):356-62. PubMed ID: 10209483
    [Abstract] [Full Text] [Related]

  • 19. DNA ploidy as a prognostic factor for patients with an adenocarcinoma in Barrett's esophagus.
    Menke-Pluymers MB, Hop WC, Mulder AH, Tilanus HW.
    Hepatogastroenterology; 1995 Dec; 42(6):786-8. PubMed ID: 8847023
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.